Full-Time

Senior/Principal Scientist

Machine Learning

Posted on 7/3/2024

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology company creating health and sustainability ventures

No salary listed

Senior

Cambridge, MA, USA

Category
Applied Machine Learning
Deep Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Python
Tensorflow
Pytorch
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Flagship Pioneering referral from your network.

đź’ˇ

Applications through a referral are 3x more likely to get an interview!

Requirements
  • PhD in a computational field (e.g., machine learning, computer science, applied math, neuroscience, computational biology, physics, etc.)
  • Strong publication record in deep learning research, particularly with large language models
  • Prior industry experience (3+ years)
  • Fluency in Python and standard ML tools and packages and libraries (e.g. PyTorch, TensorFlow, Jax, sklearn)
  • Motivated and team oriented, with an ability to thrive in a multidisciplinary environment
  • Excellent communication and presentation skills
  • Must be able to think independently and work collaboratively
  • Management and leadership experience preferred
Responsibilities
  • Lead the development of advanced ML tools that capture and recapitulate psychological phenomena.
  • Design & run key experiments of LLM-based multi-agent systems.
  • Leverage real-world data to fine-tune and validate agent behavior.
  • Design an optimized data pipeline to facilitate development, scalability, and integration with a user-facing product.
  • Experiment with techniques to augment the performance of the platform.
  • Collaborate closely with other members of the team to enhance platform KPIs.
  • Collaborate closely with software developers to integrate platform with user-facing product.
  • Communicate findings to a multi-disciplinary audience.

Flagship Pioneering focuses on creating and developing biotechnology companies that aim to produce significant advancements in human health and sustainability. The company operates by inventing platform companies, which are designed to generate multiple products that can transform these fields. Since its inception in 2000, Flagship has established over 100 scientific ventures, currently managing a diverse ecosystem of more than 40 companies, including notable names like Denali Therapeutics and Indigo Agriculture. What sets Flagship apart from its competitors is its unique approach to fostering a wide range of companies under one umbrella, allowing for collaboration and shared resources. The primary goal of Flagship Pioneering is to drive innovation in biotechnology to improve health outcomes and promote sustainable practices.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.5B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Etiome's launch with $50M aims to redefine disease progression detection.
  • Lila Sciences, backed by $200M, automates scientific discovery with AI and robotics.
  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.

What critics are saying

  • Increased competition in AI-driven discovery may lead to market saturation.
  • Over-reliance on partnerships could cause strategic misalignments or dependency issues.
  • Rapid technological advancements may challenge Flagship's ability to maintain a competitive edge.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • The company combines innovative capacity with entrepreneurial leadership and capital management.
  • Flagship Pioneering systematically produces pioneering companies through an evolutionary methodology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

VC News Daily
Apr 25th, 2025
Etiome Launches With $50M

CAMBRIDGE, MA, Etiome has announced a $50 million financing round from Flagship Pioneering.

Venture Capital
Apr 25th, 2025
Flagship Pioneering Unveils Etiome to Redefine Disease Progression Detection

Flagship Pioneering unveils Etiome to redefine disease progression detection.

Health Technology Insights
Apr 24th, 2025
Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare

Flagship Pioneering, the bioplatform innovation company, unveiled Etiome, a company redefining how Health Technology Insights.

GlobeNewswire
Mar 19th, 2025
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in...

BioPharmaTrend
Mar 11th, 2025
Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics

Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation and discovery.

INACTIVE